Vascular Access Device Market

The report "Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Global Forecast to 2031" The vascular access device market is expanding due to the rising prevalence of chronic and life-threatening diseases like cancer, renal failure, and heart disease, which require treatments such as intravenous therapy and dialysis. Additional factors include increased hospital admissions, a demand for surgical procedures, and an aging population needing repeated venous access. Furthermore, growing awareness of catheter-related bloodstream infections is driving the adoption of technologies like antimicrobial-coated catheters and safety-engineered devices. The growth of ambulatory surgical centers, home infusion therapy, and improved healthcare infrastructure in developing countries also contributes to market growth.

Browse 380 market data Tables and 65 Figures spread through 400 Pages and in-depth TOC on "Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Global Forecast to 2031 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/vascular-access-device-market-122149686.html

By type, peripheral vascular access device segment to exhibit highest CAGR during forecast period

The demand for peripheral vascular access devices is rising mainly due to the increasing incidence of chronic diseases like diabetes, cancer, and cardiovascular disorders, which necessitate patients to undergo intravenous therapy, blood sampling, and medication delivery at a regular interval. The trend of demanding reliable short-term vascular access is further supported by increasing hospital admissions, emergency care volumes, and outpatient procedures. Advanced technologies such as safety-engineered catheters, better biocompatible materials, and designs that minimize infection and needlestick injuries are fostering clinical adoption. Besides, the growth in ambulatory surgery centers, home healthcare, and value-based care models is making peripheral access devices more popular because of the easy placement, low complication rate, and reduced overall treatment cost associated with them.

By route of insertion, intravenous insertion segment to witness highest CAGR during forecast period

The use of intravenous methods for inserting vascular access devices is an accepted practice in the medical field. This method is the quickest, most efficient, and reliable way to deliver fluids, medications, blood products, and nutrients to patients in both acute and chronic care settings. The increasing frequency of chronic diseases, more and more surgical and emergency cases, and the use of chemotherapy, biologics, and critical care therapies are the main factors contributing to the rise of IV access. The advancements in IV catheter technology, safety needles, and infection control measures are making it easier to use and safer for patients. IV access is also supported by the growth of hospitals, ambulatory surgery centers, and home infusion therapy.

By end user, clinics & ambulatory care centers segment to register highest CAGR during forecast period

By end user, the clinics & ambulatory care centers segment is expected to experience the fastest growth in the vascular access device market during the forecast period. Outpatient services and same-day procedures are being increasingly adopted to lower costs and alleviate the pressure on hospitals. The large number of minimally invasive surgeries and a growing need for infusion therapy, dialysis, and chronic disease management support are some of the factors contributing to the demand for safe and efficient vascular access in non-hospital settings. Developments in vascular access devices that allow for rapid placement, reduced infection risk, and less need for training are making the switch to clinics & ambulatory care centers easier. Favorable reimbursement trends, increasing patient preference for shorter hospital stays, and the growth of standalone specialty clinics are also accelerating the use of vascular access devices in ambulatory care settings.

North America dominated global vascular access device market in 2025

The North American market for vascular access devices is growing due to the increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and renal failure. Patients with these conditions often require frequent treatments, including intravenous infusions, chemotherapy, and dialysis. The demand for vascular access products is also supported by the combination of an aging population and high volumes of procedures performed in hospitals, clinics, and ambulatory surgery centers. The use of advanced technologies like safety-engineered catheters, antimicrobial-coated devices, and ultrasound-guided placement is also a contributing factor to the expansion of the market. The presence of competent healthcare infrastructure, favorable reimbursement policies, and a primary goal of reducing the number of infections associated with catheters are some of the factors quickening the adoption of vascular access devices.?

Key Market Players

Some of the prominent players operating in the market include Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic, Plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), HealthLine Medical Products (US), Cook Medical (US), and Access Vascular, Inc. (US).

Don’t miss out on business opportunities in Vascular Access Device Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com